Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr.Siva Vijayakumar Tharumasivam, Dhanalakshmi Srinivasan University, India

Dr. T. Siva Vijayakumar (M.Sc., Ph.D., D.Sc. Honoris Causa) is a dedicated academician and accomplished researcher in Biotechnology, currently serving as Associate Dean – HRDC at Dhanalakshmi Srinivasan University, Tamil Nadu. With a dual role as Flying Officer in the Indian NCC (Airwing), his career embodies leadership in both academia and service. Dr. Vijayakumarโ€™s dynamic research covers aquatic toxicology, nanobiotechnology, neurodegenerative diseases, and regenerative medicine. He has guided numerous students in pioneering scientific exploration and has authored over 48 publications in reputed journals. A passionate mentor, he integrates innovative methodologies in research and education, ensuring his students gain holistic scientific exposure. His expertise has earned national recognition, contributing to scientific knowledge and societal progress. Committed to sustainable solutions, his work addresses pressing environmental and health challenges through nanoscience and biotechnology. His impactful contributions continue to inspire emerging scientists and institutions alike. ๐ŸŒฟ๐Ÿ”ฌ๐Ÿ‡ฎ๐Ÿ‡ณ

Publication Profile

google scholar

Education

Dr. Siva Vijayakumar pursued his Master of Science (M.Sc.) in Biotechnology, followed by a Doctor of Philosophy (Ph.D.), with an academic journey grounded in molecular biology, toxicology, and applied nanoscience. Recognized for his significant contributions to the field, he was conferred with a Doctor of Science (D.Sc.) Honoris Causa by the International Agency for Standards and Rating in 2021. His education reflects a strong emphasis on multidisciplinary integration, blending core biological sciences with technological innovations. He has continually upgraded his scientific expertise through hands-on research, workshops, and training programs. His educational foundation has enabled him to bridge theoretical knowledge with practical applications in fields such as drug delivery, aquatic environmental health, and regenerative biology. Through his academic pursuits, he has mentored future scientists, instilling a rigorous yet innovative approach to biotechnology. ๐Ÿ“˜๐Ÿงฌ๐ŸŽ“

Experience

Dr. Vijayakumar has over a decade of teaching and research experience in biotechnology. Currently, he holds the position of Associate Dean – Human Resource Development Centre (HRDC) at the Department of Biotechnology, Dhanalakshmi Srinivasan University, Tamil Nadu. He also serves as a Flying Officer and Associate NCC Officer (3TN Air Squadron NCC, Trichy), promoting discipline and patriotism among students. His academic leadership spans curriculum development, research mentoring, and interdisciplinary program coordination. He has played a pivotal role in conducting national workshops, guiding research scholars, and collaborating on funded projects. His administrative experience has fortified institutional growth through strategic planning and research integration. As a faculty member and leader, heโ€™s known for fusing technology with biological sciences, emphasizing innovation, and cultivating global scientific perspectives among students. ๐Ÿงช๐Ÿ“šโœˆ๏ธ

Awards and Honors

Dr. Siva Vijayakumar has been honored with several prestigious awards recognizing his excellence in research and education. Notable among them is the Guru Samman Award 2025 ๐Ÿง‘โ€๐Ÿซ by AISPCPA, Bengaluru, and the Innovative Research Award 2023 ๐Ÿง  by Rover Agricultural College, Perambalur. In 2021, he received the Honorary Doctorate in Biotechnology (D.Sc.) ๐ŸŽ“ and the Research Excellence Award ๐Ÿ† by the Institute of Scholars. His early research acumen earned him the Young Investigator Award 2020 ๐Ÿ” from DERO and the Best Young Scientist Award 2017 ๐Ÿงฌ by PEARL Foundation. These accolades reflect his dedication to advancing biotechnology, inspiring students, and contributing meaningfully to scientific society. His recognition across both academic and service domains illustrates a career committed to innovation, leadership, and impact. ๐ŸŒŸ๐Ÿ…

Research Focus

Dr. Vijayakumar’s primary research revolves around Aquatic Toxicology and Nanobiotechnology, emphasizing the impact of engineered nanomaterials (ENMs) on aquatic ecosystems. He investigates the toxicity, transport, bioaccumulation, and ecological impact of nanoparticles, including their genotoxic and ecotoxic consequences. His research extends to drug delivery systems, exploring biocompatibility, host responses, and novel therapeutics for neurodegenerative diseases and tissue regeneration. His interdisciplinary approach bridges molecular biology, environmental science, and materials engineering. A strong advocate for eco-safe nanotechnology, he integrates in vitro, in vivo, and computational models to assess risk and functionality. His team engages in animal model studies, molecular simulations, and regenerative biomaterial design, contributing to innovations in environmental health and biomedical applications. His vision is to foster sustainable and safe biotechnological advancements for future healthcare and environmental well-being. ๐ŸŒŠ๐Ÿงช๐Ÿง 

Publication Top Notes

  1. ๐Ÿงฌ Exploring Piperine as a Potential Treatment for Polycystic Ovarian Syndrome: Insights from In-silico Docking Studies (2024)

  2. ๐ŸŸ Toxicity Assessment on Haematology and Enzymological Alterations of Alโ‚‚Oโ‚ƒ Nanoparticles Exposed Freshwater Fish (2024)

  3. ๐ŸŒฟ Exploring Potential Anti-aging Compounds and Binding Affinity of Resveratrol with hTERT Gene (2024)

  4. ๐Ÿง  Computational Analysis of Anti-Alzheimerโ€™s Efficacy of Myristicin from Nutmeg (2024)

  5. ๐Ÿงซ Characterization of Novel Antimicrobial Peptides from Clarias Batrachus (2024)

  6. ๐Ÿ’ง Carbon Nanoparticles Fabricated Microfilm for Microplastics Filtration (2023)

  7. ๐Ÿฉน Functional 2D Graphene Oxide in the Wound Healing Process (2023)

  8. ๐Ÿฆ Probiotics-Infused Withania Somnifera for Shrimp Development (2023)

  9. ๐Ÿงช Fabrication of Silver Nanoparticles using Illicium Verum and Its Anti-bacterial Activity (2023)

  10. ๐Ÿ‡ Pharmacological Properties and Mode of Action of Quercetin: A Bioactive Flavonoid (2023)

  11. ๐ŸŒฑ Anti-inflammatory Activity of Ocimum Tenuiflorum-loaded Chitosan Nanoparticles (2023)

  12. ๐Ÿงฌ Complete Overview of Enzymatic Responses in Nanoparticle-Stressed Fish Models (upcoming)

Anna Lankoff | Genetics and Molecular Biology | Best Researcher Award

Anna Lankoff | Genetics and Molecular Biology | Best Researcher Award

Prof Anna Lankoff, Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Poland

Prof. Anna Lankoff is a distinguished scientist and educator renowned for her contributions to genotoxicology, nanotoxicology, and radiobiology. ๐Ÿ‘ฉโ€๐Ÿ”ฌ๐Ÿงช With over three decades of experience, she has made groundbreaking advancements in the study of ionizing radiation-induced DNA damage, nanoparticle-based radioconjugates for cancer therapy, and cellular responses to nanomaterials. ๐ŸŒ๐Ÿ”ฌ Currently, she holds full professorships at both the Institute of Nuclear Chemistry and Technology in Warsaw and Jan Kochanowski University in Kielce, where she leads the Cytogenetics and Genotoxicology Laboratories. ๐Ÿ’ก๐Ÿ“˜ Her collaborative work spans across institutions in Germany, Finland, Belgium, and the USA. She is a respected academic leader, actively participating in global expert committees including WHO-IARC and the European Radiation Research Council. ๐ŸŒ๐Ÿ“š With 85 peer-reviewed papers, 3797 citations, and an h-index of 30, Prof. Lankoff exemplifies excellence in research and education, making her an ideal candidate for the Best Researcher Award. ๐Ÿ†๐Ÿ”

Publication Profile

Orcid

Educationย 

Prof. Anna Lankoff began her academic journey with an MSc in Biology (1986โ€“1991) from Jan Kochanowski University, Kielce, Poland. ๐ŸŽ“๐Ÿ”ฌ She earned her PhD in Toxicology in 1999 from Maria Sklodowska-Curie University in Lublin, Poland. ๐Ÿ’Š๐Ÿ“˜ Her research prowess led her to complete a prestigious postdoctoral fellowship in 2003 at Wright State University in Dayton, Ohio, USA, in the Department of Biological Sciences. ๐ŸŒ๐Ÿงฌ In 2007, she achieved her DSc (habilitation) in Biological Sciences from the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. ๐Ÿงซ๐Ÿ“– By 2014, she was awarded the title of Full Professor in Biological Sciences, marking a significant milestone in her academic career. ๐ŸŒŸ Her extensive academic preparation laid the foundation for a prolific scientific and educational path in radiobiology, cytogenetics, and nanotoxicology. ๐Ÿง ๐Ÿ’ผ

Experienceย 

Prof. Lankoff has an extensive academic and research career. Since 2014, she has been a Full Professor at both the Institute of Nuclear Chemistry and Technology, Warsaw, and Jan Kochanowski University, Kielce. ๐Ÿงช๐Ÿ‡ต๐Ÿ‡ฑ She leads laboratories in cytogenetics and genotoxicology. From 2009โ€“2014, she served as Associate Professor at these institutions, and previously, as a lecturer and assistant since 1991. ๐Ÿ“˜๐Ÿ‘ฉโ€๐Ÿซ Her international experience includes research stints at University of Duisburg-Essen (Germany), Wright State University (USA), VITO (Belgium), and ร…bo Akademi University (Finland). ๐ŸŒ๐Ÿ” She has mentored numerous students and professionals in molecular biology, immunology, and nanotoxicology. Her professional journey reflects dedication to excellence in both teaching and cutting-edge scientific research. ๐Ÿ’ก๐Ÿงฌ

Awards and Honorsย 

Prof. Anna Lankoffโ€™s contributions have been recognized internationally. ๐ŸŒŸ She was a working group member for the WHO-IARC (2006) and an expert for the EUโ€™s โ€œEpigenetic effectsโ€ radiation protection group (2017). ๐ŸŒ๐Ÿ”ฌ She represented Poland on the ISO Radiology Standards Committee (2010โ€“2015) and serves on the Scientific Council of the Institute of Nuclear Chemistry and Technology and the Polish Society for Radiation Research. ๐Ÿ‡ต๐Ÿ‡ฑ๐Ÿ“˜ She is also a member of the European Radiation Research Council since 2022. ๐Ÿงช๐Ÿ’ก Her work has earned her recognition for developing standards in biological dosimetry and contributions to nanotoxicology and radiation biology. ๐Ÿ“œ๐Ÿ” With a prolific academic record of 85 JCR-listed publications and over 3,700 citations, she holds an h-index of 30. ๐Ÿ“š Her impactful global collaborations, editorial work, and advisory roles highlight her as a true leader in radiobiological research and innovation. ๐Ÿงฌ๐Ÿ†

Research Focusย 

Prof. Lankoffโ€™s research integrates nanotechnology, radiobiology, and molecular biology. ๐Ÿงฌ Her focus areas include the genotoxicity and cytotoxicity of nanomaterials, development of nanoparticle-based radioconjugates for targeted cancer diagnosis and therapy, and the mechanisms of DNA damage and repair induced by ionizing radiation. ๐Ÿ’ฅ๐Ÿงช She investigates cellular responses such as cell cycle arrest, apoptosis, and pyroptosis in reaction to nanomaterial exposure and radiation treatment. ๐Ÿงซ Her recent work explores nanotheranostics, blackcurrant-derived antioxidants, and radiosensitization strategies using natural compounds. ๐ŸŒฟ๐Ÿ’‰ She also delves into biodistribution, pharmacokinetics of engineered nanostructures, and radiobiological safety, bridging basic science with translational medicine. ๐ŸŒ๐Ÿง  Prof. Lankoffโ€™s innovative research contributes to the development of safer nanomaterials and more effective cancer therapies, reinforcing her status as a pioneering researcher in modern molecular and radiation biology. ๐Ÿงช๐Ÿ”ฌ๐Ÿ“ˆ

Publication Top Notes

  1. ๐Ÿ“˜ Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years (2024)

  2. ๐Ÿงช Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer (2023)

  3. โ˜ข๏ธ Hypothermia Modulates NBS1, ฮณH2AX and 53BP1 Foci in U2OS Cells Post Gamma Radiation (2022)

  4. ๐Ÿ‡ Blackcurrant Pomace Protects Rats from Testicular Oxidative Stress from Biodiesel Exhaust (2022)

  5. ๐Ÿ”ฌ Surface Modification of Gold Nanoparticles Triggers Pyroptosis-Inducing Cytokine Release (2022)

  6. ๐Ÿ’‰ Targeted NaA Nanozeolites for Prostate Cancer Therapy: Toxicity and Pharmacokinetics (2021)

  7. ๐Ÿงฌ Cisplatin Lowers Radiotherapy-Induced Micronuclei in Lymphocytes of Gynaecological Cancer Patients (2021)

  8. ๐Ÿ“ˆ Coralyne Radiosensitizes A549 Cells by CDKN1A Upregulation Affecting G2/M Cell Cycle Arrest (2021)